Stocks Health care KMTS
NASDAQ · Health careKestra Medical Technologies, Ltd. (KMTS)
Kestra Medical Technologies, Ltd. brought in $106.7M of revenue over the twelve months to July 31, 2026, up 60.7% from a year earlier. It posted a net loss of $149.9M. In fiscal 2026 capital spending exceeded operating cash flow by $116.6M. At July 31, 2026 it held $68.6M in cash against $72.5M of debt. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on September 14, 2026.
What Kestra Medical Technologies, Ltd. does
Kestra Medical Technologies, Ltd. is registered with the SEC under industry code SIC 3841 (Surgical & Medical Instruments & Apparatus). Its shares trade on NASDAQ under the ticker KMTS.
Revenue and profit by year
Key figures
| Fiscal year | Revenue | Net income | Diluted EPS | Free cash flow |
|---|---|---|---|---|
| 2026 | $95.1M | -$131.6M | -$2.43 | -$116.6M |
| 2025 | $59.8M | -$113.8M | -$5.13 | -$100.5M |
| 2025 | $27.8M | -$94.1M | -$5.07 | -$84.5M |
Latest SEC filings
What Kestra Medical Technologies, Ltd. has filed recently, newest first. Each links to the original document on SEC EDGAR.
- September 14, 2026Quarterly report 10-Q · period to July 31, 2026
- September 14, 2026
- September 10, 2026
- August 14, 2026Passive stake changed SCHEDULE 13G/A
- July 28, 2026
- July 28, 2026Additional proxy material DEFA14A
- July 28, 2026Proxy statement DEF 14A
- July 14, 2026Annual report 10-K · period to April 30, 2026
- July 14, 2026
- April 8, 2026Passive stake changed SCHEDULE 13G/A
Questions about KMTS
What does Kestra Medical Technologies, Ltd. do?
Kestra Medical Technologies, Ltd. is registered with the SEC under industry code SIC 3841 (Surgical & Medical Instruments & Apparatus). Its shares trade on NASDAQ under the ticker KMTS.
Is Kestra Medical Technologies, Ltd. profitable?
No. Over the twelve months to July 31, 2026 it reported a net loss of $149.9M on revenue of $106.7M.
How much revenue does Kestra Medical Technologies, Ltd. make?
Over the twelve months to July 31, 2026 Kestra Medical Technologies, Ltd. reported revenue of $106.7M. That is 60.7% more than a year earlier.
When did Kestra Medical Technologies, Ltd. last report?
Its most recent periodic report is the quarterly report (10-Q) filed on September 14, 2026. It covers the period to July 31, 2026. Its newest filing of any kind is the insider trade from September 23, 2026.
Similar companies
Follow KMTS
Get an email when Kestra Medical Technologies, Ltd. files with the SEC: results, executive changes, material agreements and annual reports.
Follow KMTS: get an email when it filesWhere the numbers come from
Financial figures are the values Kestra Medical Technologies, Ltd. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.
Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.